BioCardia, Inc. (BCDA) Pre-Tax Margin
- 2016-09-30: Pre-Tax Margin 4376.92%.
- 2016-06-30: Pre-Tax Margin 52.08%.
- 2016-03-31: Pre-Tax Margin 46.07%.
- 2012-09-30: Pre-Tax Margin -426.32%.
Complete source-backed pre-tax margin history.
- Available history
- 2012-03-31 to 2016-09-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2016-09-30 | 4376.92% |
| 2016-06-30 | 52.08% |
| 2016-03-31 | 46.07% |
| 2012-09-30 | -426.32% |
| 2012-06-30 | -758.82% |
| 2012-03-31 | -500.00% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2015-12-31 | 35.62% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |